SCHEMBL15312965

SCHEMBL15312965

CCOC(=O)C(C)=C1COC1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GLO1 Q04760 1/20 0.39
ALDH1A1 P00352 8/20 0.39
LMNA P02545 2/20 0.39
HSD17B10 Q99714 1/20 0.39
MAPT P10636 3/20 0.38
GAA P10253 2/20 0.38
HPGD P15428 1/20 0.38
MPI P34949 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TSHR P16473 2/20 0.36
NPSR1 Q6W5P4 1/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
ATM Q13315 1/20 0.34
GLA P06280 1/20 0.34
RECQL P46063 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19095447 0.85 TSHR (0.36) GLO1ALDH1A1LMNAHSD17B10MAPT
SCHEMBL19095446 0.85 TSHR (0.36) GLO1ALDH1A1LMNAHSD17B10MAPT
SCHEMBL3879787 0.81 TSHR (0.42) GLO1ALDH1A1LMNAHSD17B10MAPT
SCHEMBL7041913 0.76 GLO1 (0.39) GLO1ALDH1A1LMNAHSD17B10MAPT
SCHEMBL25547583 0.76 GLO1 (0.39) GLO1ALDH1A1LMNAHSD17B10MAPT
SCHEMBL2864246 0.73 GLO1 (0.37) GLO1ALDH1A1LMNAHSD17B10MAPT
SCHEMBL1189435 0.72 ALDH1A1 (0.42) GLO1ALDH1A1LMNAHSD17B10MAPT
SCHEMBL21061394 0.72 ALDH1A1 (0.37) GLO1ALDH1A1LMNAMAPTGAA
SCHEMBL30969049 0.72 LMNA (0.36) GLO1ALDH1A1LMNAHSD17B10MAPT
Hydrochloric Acid SCHEMBL3547234 0.72 ADORA1 (0.38) GLO1ALDH1A1LMNAHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9447080-B2 Viral polymerase inhibitors BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) 2016-09-20 US disclosed
US-9447080-B2 Viral polymerase inhibitors BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) 2016-09-20 US disclosed
US-9365554-B2 Viral polymerase inhibitors AVIRAGEN THERAPEUTICS, INC. (US) 2016-06-14 US disclosed
US-9365554-B2 Viral polymerase inhibitors AVIRAGEN THERAPEUTICS, INC. (US) 2016-06-14 US disclosed
US-9120775-B2 Viral polymerase inhibitors BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2015-09-01 US disclosed
US-9120775-B2 Viral polymerase inhibitors BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2015-09-01 US disclosed
US-20150175592-A1 Viral Polymerase Inhibitors BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2015-06-25 US disclosed
US-20150175592-A1 Viral Polymerase Inhibitors BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2015-06-25 US disclosed
US-20150065445-A1 Viral Polymerase Inhibitors BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) 2015-03-05 US disclosed
US-20150065445-A1 Viral Polymerase Inhibitors BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) 2015-03-05 US disclosed
US-8785478-B2 Viral polymerase inhibitors BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) 2014-07-22 US disclosed
US-8785478-B2 Viral polymerase inhibitors BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) 2014-07-22 US disclosed
WO-2013152391-A1 VIRAL POLYMERASE INHIBITORS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-10-17 WO disclosed
WO-2013152392-A1 VIRAL POLYMERASE INHIBITORS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-10-17 WO disclosed
US-20130274179-A1 VIRAL POLYMERASE INHIBITORS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-10-17 US disclosed
US-20130274218-A1 VIRAL POLYMERASE INHIBITORS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-10-17 US disclosed
US-20130274179-A1 VIRAL POLYMERASE INHIBITORS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-10-17 US disclosed
US-20130274218-A1 VIRAL POLYMERASE INHIBITORS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175592-A1 Viral Polymerase Inhibitors POLR2E, POLM, POLR2H GLO1 1211/4885ALDH1A1 477/4885LMNA 2218/4885
US-20150065445-A1 Viral Polymerase Inhibitors POLR2E, POLM, POLR2H GLO1 1211/4885ALDH1A1 477/4885LMNA 2218/4885
US-20130274218-A1 VIRAL POLYMERASE INHIBITORS POLR2E, POLM, POLR2H GLO1 1211/4885ALDH1A1 477/4885LMNA 2218/4885
US-20130274179-A1 VIRAL POLYMERASE INHIBITORS POLR2E, POLM, POLR2H GLO1 1211/4885ALDH1A1 477/4885LMNA 2218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.